DTC Marketing

As the pharmaceutical industry moves beyond rule-based omnichannel marketing, a new era of agentic systems is emerging, in which AI-powered agents collaborate with humans to orchestrate engagement, accelerate decision-making, and maintain regulatory compliance in real time.

A look back and ahead at the growing trend—sparked recently by the GLP-1 trail—and new ways to harness this Rx access channel for positive outcomes.

Krishna discusses why the time was right to take the marketing directly to the patients.

The intersection of artificial intelligence and direct-to-consumer advertising presents unprecedented opportunities and evolving challenges as regulations and technologies reshape the biopharma landscape.

The bill is in line with comments RFK Jr. has made about this form of advertising.

Starting July 7, 2025, the two highest doses of Zepbound will be available for a flat price of $499 per month, with shipments beginning in August.

The agent, named eVa, can replace multiple tools for marketers.

The project is being developed in partnership with Insulet Corporation.

The Care Collective will provide marketing opportunities for tv, streaming, and digital platforms.

The move comes as FDA’s grace period for compounded GLP-1s comes to an end.

As the FDA’s ban on mass compounding of semaglutide takes effect, Novo Nordisk introduces discounted pricing and new patient resources to ensure safe access to Wegovy.

The ad is the latest DTC content from SK Life Science.

Supernus Pharmaceuticals’ campaign aims to raise awareness about issues women face even getting diagnosed with ADHD.

The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children are vaccinated against all strains.

Sonam Dubey, a partner at Beghou Consulting, discusses the potential impact of a possible ban on direct-to-consumer advertising amid policy and government agency overhauls in the US.

The I LUVY YA for The Long Haul campaign features stories about the emotional impact of the disease.

The line-up consists of supplements to meet the health needs to patients taking GLP-1 medications for weight loss.

eHealth’s latest survey reveals Americans give the nation’s healthcare system a low grade and are open to significant changes.

Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.

In this Q&A, Organon's Chief Communications Officer, Becky Edwards discusses how much social media and influencers sway decisions about birth control methods, potential consequences of these misinformed choices, and more.

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.